Planet Saturn, observed by the Cassini space probe on March 16, 2016.
CRISPR/Cas Just Got About One Hundred Million Dollars Hotter
CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated announced that they will be entering into a 105 million USD strategic research collaboration focused on developing therapeutics for genetic disease.
In more detail, what does that mean? A number of genetic mutations are responsible for inherited diseases, and two examples of this are cystic fibrosis and sickle cell anaemia.
Cystic fibrosis (CF) is caused by mutations within the CFTR gene which lead to a broken or non-folding protein, this in turn prevents the proper dilution of mucosal secretions and thus leads to numerous pathologies. Sickle cell anaemia/disease, by contrast, is due to mutations within the gene coding for haemoglobin leading to protein aggregation and disruption of red blood cell structures. It is predominantly found in descendants from malaria-prone areas, as the mutation – at least in heterozygotes – provides innate resistance against malarial infection.
The collaboration between Vertex and CRISPR will initially focus on developing therapeutics for cystic fibrosis and sickle cell anaemia, with other unspecified genes also on the target list
Full Story: Syniobeta
I originally started making this material not necessarily for armors but more for cars and trains. [I wanted it] to squeeze like a sponge, but in a heavy duty kind of form of a sponge so we could put it in front of the car or a high speed train and take care of the impact. But when we saw the performance of the material, we started thinking about ballistics and bullets. And so I tested those and we saw that…the material can perform.
Afsaneh Rabiei. He developed a metal foam that is lightweight, strong, heat- and radiation-resistant, and, when incorporated in a bulletproof vest, for example, capable of shattering bullets on impact without injuring the person wearing it.
(via sciencefriday)
Though small amounts of copper are essential to health - oysters, liver, beans and nuts are good sources - copper’s role in metabolism has been unclear: Some studies found that it boosted fat burning, others that it depressed it.
University of California, Berkeley, Lawrence Berkeley National Laboratory and Howard Hughes Medical Institute researchers have now clarified the critical role that copper plays in nutrition: It helps move fat out of fat cells - called adipocytes - and into the blood stream for use as energy.
Without enough copper, fat builds up in fat cells without being utilized, said Christopher Chang, the Class of 1942 Chair and a professor of chemistry and of molecular and cell biology at UC Berkeley.
“Unlike other studies that link copper levels both to increased or decreased fat metabolism, our study shows definitively how it works - it’s a signal that turns on fat cells,” said Chang, who also is a faculty scientist at Berkeley Lab and a Howard Hughes Medical Institute investigator. “If we could find a way to burn fat more efficiently, this could be a big contribution to dealing with obesity and diabetes.”
The new study appeared online this week, and will be published in the July print issue of the journal Nature Chemical Biology.
“Copper regulates cyclic-AMP-dependent lipolysis” by Lakshmi Krishnamoorthy, Joseph A Cotruvo Jr, Jefferson Chan, Harini Kaluarachchi, Abigael Muchenditsi, Venkata S Pendyala, Shang Jia, Allegra T Aron, Cheri M Ackerman, Mark N Vander Wal, Timothy Guan, Lukas P Smaga, Samouil L Farhi, Elizabeth J New, Svetlana Lutsenko and Christopher J Chang in Nature Chemical Biology. Published online June 6 2016 doi:10.1038/nchembio.2098
Caption: The crystal structure of the cAMP-degrading enzyme phosphodiesterase PDE3B, showing two magnesium atoms (green) in the active site. Copper binds one of the amino acid residues in the pink loop at the left, blocking the activity of the enzyme. Credit: Lakshmipriya Krishnamoorthy and Joseph Cotruvo Jr., UC Berkeley
Since October, northeastern Brazil has been devastated by a wave of microcephaly, a condition where babies are born with abnormally small heads and damaged brains. At this moment, all signs point to the mosquito-borne Zika, a little-studied virus normally associated only with rashes, fever, and other mild symptoms. In the months since Brazil sounded the alarm, Zika cases have been popped up in a dozen other countries, and health authorities predict the virus will spread across the Americas. Infectious disease specialist Michael Osterolm explains what’s known about Zika, and what we can expect as this outbreak unfolds.